Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Helicobacter pylori--2002].

G Treiber1, P Malfertheiner

  • 1Klinik für Gastroenterologie/Hepatologie/Infektiologie, Otto-von-Guericke-Universität Magdeburg.

Praxis
|June 20, 2002
PubMed
Summary

Effective Helicobacter pylori eradication therapy involves specific first-line triple therapy (proton pump inhibitor, clarithromycin, amoxicillin/metronidazole) and second-line quadruple therapy. Confirmation of H. pylori eradication is crucial via urea breath test or other indicated methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultra-long pharmacokinetic properties of insulin degludec are comparable in elderly subjects and younger adults with type 1 diabetes mellitus.

Drugs & aging·2013
Same author

Pharmacodynamics of the long-acting insulin analogues detemir and glargine following single-doses and under steady-state conditions in patients with type 1 diabetes.

Diabetes, obesity & metabolism·2013
Same author

S3-guideline "helicobacter pylori and gastroduodenal ulcer disease" of the German society for digestive and metabolic diseases (DGVS) in cooperation with the German society for hygiene and microbiology, society for pediatric gastroenterology and nutrition e. V., German society for rheumatology, AWMF-registration-no. 021 / 001.

Zeitschrift fur Gastroenterologie·2009
Same author

The placebo response in functional dyspepsia--reanalysis of trial data.

Neurogastroenterology and motility·2009
Same author

Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study.

Alimentary pharmacology & therapeutics·2009
Same author

[S3-guideline "Helicobacter pylori and gastroduodenal ulcer disease"].

Zeitschrift fur Gastroenterologie·2009

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Pharmacology

Background:

  • Helicobacter pylori infection is a significant factor in peptic ulcer disease, MALT lymphoma, and atrophic gastritis.
  • Treatment is also recommended for relatives of gastric cancer patients and in specific clinical scenarios like functional dyspepsia.
  • Consideration for eradication is advised before NSAID introduction or long-term proton-pump inhibitor (PPI) use.

Purpose of the Study:

  • To outline recommended treatment strategies for H. pylori infection.
  • To define first-line and second-line eradication therapies.
  • To establish guidelines for confirming successful H. pylori eradication and for a 'test and treat' approach.

Main Methods:

  • Recommends a package approach for eradication therapy, including first and second-line options.
  • Specifies first-line triple therapy: PPI, clarithromycin, and amoxicillin or metronidazole.
  • Details second-line quadruple therapy: PPI, bismuth, metronidazole, and tetracycline, with alternatives if bismuth is unavailable.

Main Results:

  • Successful H. pylori eradication should be confirmed using urea breath test (UBT) or endoscopy-based tests.
  • Stool antigen testing is an alternative diagnostic method when UBT is not feasible.
  • A 'test and treat' strategy using non-invasive tests is suggested for specific adult dyspepsia patients.

Conclusions:

  • Eradication therapy is not associated with gastro-esophageal reflux disease (GERD) and does not impede NSAID-induced ulcer healing.
  • For uncomplicated duodenal ulcers, eradication therapy may suffice without further antisecretory treatment.
  • Referral to specialists is advised for persistent H. pylori infections after failed second-line therapy.

Related Experiment Videos